Theravance Biopharma, Inc.
2019 Q4 - 2025 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 7 | 0.0% | 399 | 12/31/2025 |
| 2024 Q4 | 2/14/2025 | 1,412 | 0.0% | 150,039 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 947 | 0.0% | 117,505 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 1,178 | 0.0% | 138,877 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 579 | 0.0% | 64,528 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 725 | 0.0% | 64,528 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 530 | 0.0% | 61,415 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 666 | 0.0% | 61,415 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 666 | 0.0% | 61,415 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 730 | 0.0% | 65,039 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 734 | 0.0% | 72,418 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 656 | 0.0% | 72,418 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 715 | 0.0% | 74,763 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 819 | 0.0% | 74,154 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 477 | 0.0% | 64,500 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 928 | 0.0% | 63,921 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 1,241 | 0.0% | 60,794 | 3/31/2021 |
| 2020 Q4 | 3/1/2021 | 1,080 | 0.0% | 60,794 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 642 | 0.0% | 43,428 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 912 | 0.0% | 43,428 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 781 | 0.0% | 33,804 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 874 | 0.0% | 33,757 | 12/31/2019 |